Skip to main content
Premium Trial:

Request an Annual Quote

Decode Genetics Gets Another Letter from Nasdaq

NEW YORK (GenomeWeb News) – Decode Genetics has received another letter from the Nasdaq Stock Exchange notifying the firm that for 30 consecutive business days the market value of its publicly traded common stock was below $15 million, which is the minimum level required for continued listing on the Nasdaq Global Market.

Decode, which filed for Chapter 11 bankruptcy protection last month, said Wednesday that Nasdaq informed the firm that it has 90 calendar days to regain compliance. Its shares must have a market value of at least $15 million for 10 consecutive business days in order to meet the exchange's regulations.

Decode received a delisting notice last month from Nasdaq after it filed for bankruptcy protection. The firm said in a filing with the US Securities and Exchange Commission this week that it has appealed the suspension and expects Nasdaq to make a decision on the appeal next month.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.